Combretastatin-A4 phosphate improves the distribution and antitumor efficacy of albumin-bound paclitaxel in W256 breast carcinoma model.
about
Combretastatin-A4 phosphate improves the distribution and antitumor efficacy of albumin-bound paclitaxel in W256 breast carcinoma model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combretastatin-A4 phosphate im ...... n W256 breast carcinoma model.
@en
Combretastatin-A4 phosphate im ...... n W256 breast carcinoma model.
@nl
type
label
Combretastatin-A4 phosphate im ...... n W256 breast carcinoma model.
@en
Combretastatin-A4 phosphate im ...... n W256 breast carcinoma model.
@nl
prefLabel
Combretastatin-A4 phosphate im ...... n W256 breast carcinoma model.
@en
Combretastatin-A4 phosphate im ...... n W256 breast carcinoma model.
@nl
P2093
P2860
P356
P1433
P1476
Combretastatin-A4 phosphate im ...... n W256 breast carcinoma model.
@en
P2093
Cuihua Jiang
Dejian Huang
Dongjian Zhang
Jian Zhang
Jindian Li
Qiaomei Jin
Shaoli Song
P2860
P304
58133-58141
P356
10.18632/ONCOTARGET.11249
P407
P577
2016-08-12T00:00:00Z